OvaRex MAb is a monoclonal antibody a biotech drug designed to help the patients immune system recognize and more effectively fight ovarian cancer. OvaRex MAb is given during the watchful waiting period, following successful front-line therapy. It may become recognized as the most significant advance in ovarian cancer treatment since the use of chemotherapy to treat this illness.
Continue reading...